Free Daily Podcast Summary
Pharma and BioTech Daily: Daily Summaries Delivered
by Pharma and BioTech News
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai , a boutique AI & data studio.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Today5 min
GlaxoSmithKline's $2.5B Restructuring Near AstraZeneca | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into the latest news shaping these dynamic sectors, exploring strategic corporate maneuvers, groundbreaking scientific advances, and pivotal regulatory changes. GlaxoSmithKline (GSK) is embarking on a comprehensive restructuring initiative aimed at achieving $2.5 billion in annual cost savings by 2029. This ambitious initiative underscores the co...
- Yesterday4 min
AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a wealth of significant advancements and strategic moves shaping the industry landscape. AstraZeneca is making waves with its steadfast commitment to reaching an $80 billion revenue target by 2030. This ambitious goal is underpinned by strong sales in oncology and rare disease treatments, despite some setbacks with underperforming drugs...
- 2 days ago5 min
Scribe Therapeutics Raises $129M in IPO | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into the latest groundbreaking advancements, strategic corporate maneuvers, and pivotal regulatory updates shaping this dynamic industry landscape. Starting with some exciting news, Scribe Therapeutics has successfully closed its initial public offering, raising a significant $129 million. This substantial funding will drive forward their pi...
- 5 days ago4 min
Eli Lilly's Retatrutide: 22.6% Weight Loss in Phase 3! | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some of the most exciting scientific breakthroughs and regulatory developments that are shaping the future of healthcare. Eli Lilly's retatrutide, a promising small molecule GLP-1 receptor agonist, has achieved significant results in Phase 3 trials, leading to an impressive 22.6% weight loss in patients with obesity and cardiovascular d...
- 6 days ago5 min
Repligen Buys BioLife for $1.5B | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're delving into a series of significant breakthroughs and strategic moves reshaping the industry landscape. Repligen Corporation's recent decision to acquire BioLife Solutions for $1.5 billion marks a pivotal moment in the cell therapy sector. BioLife Solutions' expertise in cryopreservation media is integral to maintaining cell viability during stora...
- 1 weeks ago4 min
Bristol Myers & NVIDIA's $1.5B AI Deal: Game Changer? | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Recent advancements in these sectors highlight a fascinating intersection of technology and medicine, underscoring a push towards innovation that promises to reshape healthcare delivery. Bristol Myers Squibb has expanded its collaboration with NVIDIA, aiming to create what could become the most powerful AI infrastructure dedicated to life sciences. This partner...
- 1 weeks ago5 min
Samsung Biologics' $1.8B Peptide Expansion | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're navigating through a myriad of transformative advancements reshaping the industry. From artificial intelligence-driven research breakthroughs to strategic acquisitions in emerging therapeutic areas, these developments are setting new benchmarks in drug discovery and patient care. **Strategic Acquisitions and Expansions:** Samsung Biologics' recent ...
- 1 weeks ago5 min
Jasper Merges with Kira for $292M | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of industry-shaping events, reflecting the ever-evolving landscape of drug development, regulatory challenges, and strategic maneuvers. In a significant move within the sector, Jasper Therapeutics has merged with Kira Pharmaceuticals, a strategic decision aimed at expanding its footprint in autoimmune therapeutics. This merger brin...
Get Pharma and BioTech Daily summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Bloomberg Tech
Daily news and analysis on global tech companies, innovation, and the future of business.
Bloomberg Intelligence
Analysis of Wall Street investments and company research from Bloomberg Intelligence experts.
The Anthropic AI Daily Brief
Breaks down Anthropic's latest AI advancements and their real-world implications in clear, accessible language.
Morning Brew Daily
A daily breakdown of business, economic, and general news with a witty and informative approach to start your day.
Everyday AI Podcast – An AI and ChatGPT Podcast
Practical AI and ChatGPT tips for professionals to improve productivity and grow their careers.
The Best One Yet
Daily business news explained through sharp analysis and witty commentary, delivered in concise 20-minute episodes.
Stock Movers
Daily analysis of top-performing and struggling stocks across global markets, covering major sectors and breaking investment news.
Pivot
Sharp, unfiltered analysis of tech, business, and politics with bold predictions and lively debate.
The Digital Executive
A daily tech podcast exploring emerging technologies through interviews with Silicon Valley CEOs, influencers, and celebrities.
The AI Daily Brief: Artificial Intelligence News and Analysis
A daily analysis of artificial intelligence news, exploring its creative potential, industry impacts, and ethical challenges.
Moonshots with Peter Diamandis
Explores emerging technologies and their potential to transform humanity's future.
Bloomberg Intelligence
Market analysis and financial insights from Bloomberg experts and newsmakers as Wall Street opens.
About Pharma and BioTech Daily
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai , a boutique AI & data studio.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Pharma and BioTech Daily in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Pharma and BioTech Daily daily summary?
It's a free AI-powered email that summarizes new episodes of Pharma and BioTech Daily as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Pharma and BioTech Daily podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Pharma and BioTech Daily product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Pharma and BioTech News.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Pharma and BioTech Daily release new episodes?
Pharma and BioTech Daily publishes daily. Our AI generates a summary within hours of each new episode.
What topics does Pharma and BioTech Daily cover?
Pharma and BioTech Daily covers topics including Science, News, Business, Investing, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Pharma and BioTech Daily summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.